Principal Financial Group Inc Clovis Oncology, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$1.05 - $2.85 $159,332 - $432,473	-151,745 Reduced 59.42%	103,638 $123,000
Q2 2022 Aug 10, 2022	SELL	$0.63 - $2.96 $30,434 - $142,991	-48,308 Reduced 15.91%	255,383 $460,000
Q1 2022 May 09, 2022	SELL	$1.43 - $3.14 $194,105 - $426,217	-135,738 Reduced 30.89%	303,691 $614,000
Q4 2021 Feb 09, 2022	SELL	$2.7 - $4.76 $667,642 - $1.18 Million	-247,275 Reduced 36.01%	439,429 $1.19 Million
Q3 2021 Nov 09, 2021	BUY	$4.06 - $5.8 $129,684 - $185,263	31,942 Added 4.88%	686,704 $3.06 Million
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $1.7 Million - $2.39 Million	339,453 Added 107.66%	654,762 $3.8 Million
Q1 2021 May 10, 2021	BUY	$4.81 - $10.34 $90,928 - $195,467	18,904 Added 6.38%	315,309 $2.21 Million
Q4 2020 Feb 08, 2021	SELL	$4.13 - $6.41 $669,303 - $1.04 Million	-162,059 Reduced 35.35%	296,405 $1.42 Million
Q3 2020 Nov 06, 2020	BUY	$4.82 - $7.72 $974,849 - $1.56 Million	202,251 Added 78.94%	458,464 $2.67 Million
Q2 2020 Aug 05, 2020	BUY	$5.69 - $9.69 $1.46 Million - $2.48 Million	256,213 New	256,213 $1.73 Million
Q4 2019 Feb 05, 2020	SELL	$3.0 - $16.43 $232,533 - $1.27 Million	-77,511 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$3.93 - $15.35 $28,500 - $111,318	-7,252 Reduced 8.56%	77,511 $305,000
Q2 2019 Aug 12, 2019	SELL	$12.81 - $25.67 $1,870 - $3,747	-146 Reduced 0.17%	84,763 $1.26 Million
Q1 2019 May 10, 2019	BUY	$17.66 - $30.28 $96,794 - $165,964	5,481 Added 6.9%	84,909 $2.11 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $113,950 - $320,100	-9,798 Reduced 10.98%	79,428 $1.43 Million
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $30,662 - $51,657	-1,044 Reduced 1.16%	89,226 $2.62 Million
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $1.09 Million - $1.61 Million	25,833 Added 40.09%	90,270 $0
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $2,054 - $2,776	-41 Reduced 0.06%	64,437 $3.4 Million
Q4 2017 Feb 13, 2018	BUY	$57.69 - $84.58 $1.02 Million - $1.5 Million	17,762 Added 38.02%	64,478 $4.39 Million
Q3 2017 Nov 02, 2017	BUY	$67.17 - $84.81 $3.14 Million - $3.96 Million	46,716	46,716 $3.85 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account